G-quadruplexes: a promising target for cancer therapy

N Kosiol, S Juranek, P Brossart, A Heine, K Paeschke - Molecular Cancer, 2021 - Springer
DNA and RNA can fold into a variety of alternative conformations. In recent years, a
particular nucleic acid structure was discussed to play a role in malignant transformation and …

[HTML][HTML] Small molecules targeting c-Myc oncogene: promising anti-cancer therapeutics

BJ Chen, YL Wu, Y Tanaka, W Zhang - International journal of …, 2014 - ncbi.nlm.nih.gov
The nuclear transcription factor c-Myc is a member of the Myc gene family with multiple
functions and located on band q24. 1 of chromosome 8. The c-Myc gene is activated by …

Effects of berberine and its derivatives on cancer: A systems pharmacology review

C Zhang, J Sheng, G Li, L Zhao, Y Wang… - Frontiers in …, 2020 - frontiersin.org
Numerous studies have shown that berberine and its derivatives demonstrate important anti-
tumor effects. However, the specific underlying mechanism remains unclear. Therefore …

Pharmacological effects of berberine and its derivatives: a patent update

Y Jin, DB Khadka, WJ Cho - Expert Opinion on Therapeutic Patents, 2016 - Taylor & Francis
Introduction: A number of plant-derived agents are used in many therapeutic areas.
Berberine, an important protoberberine alkaloid, is present in a number of medicinal plants …

G-quadruplexes in c-MYC promoter as targets for cancer therapy

B Bahls, IM Aljnadi, R Emídio, E Mendes, A Paulo - Biomedicines, 2023 - mdpi.com
Cancer is a societal burden demanding innovative approaches. A major problem with the
conventional chemotherapeutic agents is their strong toxicity and other side effects due to …

Telomerase inhibitors from natural products and their anticancer potential

K Ganesan, B Xu - International journal of molecular sciences, 2017 - mdpi.com
Telomeres and telomerase are nowadays exploring traits on targets for anticancer therapy.
Telomerase is a unique reverse transcriptase enzyme, considered as a primary factor in …

Human MYC G-quadruplex: From discovery to a cancer therapeutic target

W Wang, S Hu, Y Gu, Y Yan, DB Stovall, D Li… - Biochimica et Biophysica …, 2020 - Elsevier
Overexpression of the MYC oncogene is a molecular hallmark of both cancer initiation and
progression. Targeting MYC is a logical and effective cancer therapeutic strategy. A special …

New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription

MH Hu, TY Wu, Q Huang, G Jin - Nucleic acids research, 2019 - academic.oup.com
Conventional chemotherapy remains the primary treatment option for triple-negative breast
cancer (TNBC). However, the current chemotherapeutic drugs have limited effects on TNBC …

[HTML][HTML] Major achievements in the design of quadruplex-interactive small molecules

E Mendes, IM Aljnadi, B Bahls, BL Victor, A Paulo - Pharmaceuticals, 2022 - mdpi.com
Organic small molecules that can recognize and bind to G-quadruplex and i-Motif nucleic
acids have great potential as selective drugs or as tools in drug target discovery programs …

Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations

F Moraca, J Amato, F Ortuso, A Artese… - Proceedings of the …, 2017 - National Acad Sciences
G-quadruplexes (G4s) are higher-order DNA structures typically present at promoter regions
of genes and telomeres. Here, the G4 formation decreases the replicative DNA at each cell …